BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10550832)

  • 1. The role of radiation, with or without chemotherapy, in the management of NSCLC.
    Chakravarthy A; Johnson D; Choy H
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):93-100. PubMed ID: 10550832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Concomitant radiochemotherapy for non-small-cell lung cancer: towards an ideal strategy].
    Rixe O
    Rev Mal Respir; 2001 Sep; 18(4 Pt 1):365-6. PubMed ID: 11547240
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiosensitization with chemotherapeutic agents.
    Caffo O
    Lung Cancer; 2001 Dec; 34 Suppl 4():S81-90. PubMed ID: 11742709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
    Argiris A; Liptay M; LaCombe M; Marymont M; Kies MS; Sundaresan S; Masters G
    Lung Cancer; 2004 Aug; 45(2):243-53. PubMed ID: 15246197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions.
    Bunn PA; Kelly K
    Clin Cancer Res; 1998 May; 4(5):1087-100. PubMed ID: 9607565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for non-platinum chemotherapy in advanced NSCLC.
    Murren JR
    Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):29-34. PubMed ID: 11497229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitization of vinorelbine and gemcitabine in NCI-H460 non-small-cell lung cancer cells.
    Zhang M; Boyer M; Rivory L; Hong A; Clarke S; Stevens G; Fife K
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):353-60. PubMed ID: 14751503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy for non-small cell lung cancer: have we reached a new plateau?
    Shepherd FA
    Semin Oncol; 1999 Feb; 26(1 Suppl 4):3-11. PubMed ID: 10201515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer.
    Belani CP
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):44-54. PubMed ID: 10190783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy with topotecan for non-small cell lung cancer.
    Dowlati A; Levitan N
    Lung Cancer; 2003 Aug; 41 Suppl 4():S23-6. PubMed ID: 14565511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments.
    Simon GR; Bunn PA
    Cancer Invest; 2003; 21(1):87-104. PubMed ID: 12643013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising new agents in the treatment of non-small cell lung cancer.
    Edelman MJ; Gandara DR
    Cancer Chemother Pharmacol; 1996; 37(5):385-93. PubMed ID: 8599859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topoisomerase I inhibitors combination chemotherapy in non-small cell lung cancer.
    Tumolo S; Toffoli G; Saracchini S; Lo Re G; Bruschi G; Boccieri MG
    Lung Cancer; 2001 Dec; 34 Suppl 4():S37-46. PubMed ID: 11742701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of non-small cell lung cancer in elderly patients.
    Gridelli C; Maione P; Colantuoni G; Rossi A
    Curr Med Chem; 2002 Aug; 9(16):1487-95. PubMed ID: 12171559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vinorelbine: a review of its use in elderly patients with advanced non-small cell lung cancer.
    Curran MP; Plosker GL
    Drugs Aging; 2002; 19(9):695-721. PubMed ID: 12381238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic strategy for advanced non-small cell lung cancer].
    Fukuoka M; Yoshikawa A
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):37-44. PubMed ID: 7826076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New chemotherapy agents for small cell lung cancer.
    Kelly K
    Chest; 2000 Apr; 117(4 Suppl 1):156S-162S. PubMed ID: 10777472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
    Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
    Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy in head and neck cancer. Overview of newer agents.
    Khattab J; Urba SG
    Hematol Oncol Clin North Am; 1999 Aug; 13(4):753-68. PubMed ID: 10494511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.